Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)

ClinicalTrials.gov ID: NCT03617367

Public ClinicalTrials.gov record NCT03617367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)

Study identification

NCT ID
NCT03617367
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Revance Therapeutics, Inc.
Industry
Enrollment
357 participants

Conditions and interventions

Interventions

  • daxibotulinumtoxinA for injection Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 4, 2018
Primary completion
May 24, 2021
Completion
May 24, 2021
Last update posted
Jan 27, 2022

2018 – 2021

United States locations

U.S. sites
37
U.S. states
18
U.S. cities
35
Facility City State ZIP Site status
HOPE Research Institute Phoenix Arizona 85018
Movement Disorders Center of Arizona Scottsdale Arizona 85258
The Parkinsons and Movement Disorder Institute Fountain Valley California 92708
Loma Linda University Loma Linda California 92354
USC Keck School of Medicine Los Angeles California 90033
Care Access Research LLC Pasadena California 91101
Rocky Mountain Movement Disorders Center Englewood Colorado 80113
Ki Health Partners LLC DBA New England Institute for Clinical Research Stamford Connecticut 06905
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486
University of Florida Center for Movement Disorders and Neurorestoration Gainesville Florida 32609
Infinity Clinical research Hollywood Florida 33024
University of Miami Miami Florida 33136
Suncoast Neuroscience Associates St. Petersburg Florida 33713
USF Parkinson's Disease and Movement Disorders Center Tampa Florida 33613
Emory University Atlanta Georgia 30322
Rush University Medical Center Chicago Illinois 60612
Kansas Institute of Research Overland Park Kansas 66211-1358
Michigan State University East Lansing Michigan 48824
QUEST Research Institute Farmington Michigan 48334
Henry Ford West Bloomfield Hospital West Bloomfield Michigan 48322
St Louis University St Louis Missouri 63104
Washington University St Louis Missouri 63110
University of Nebraska Medical Center Omaha Nebraska 68105
Mount Sinai Movement Disorders Center New York New York 10029
University of Rochester Rochester New York 14618
Duke University Durham North Carolina 27710
Wake Forest Health Sciences Winston-Salem North Carolina 27157
University of Pennsylvania Philadelphia Pennsylvania 19107
Coastal Neurology Port Royal South Carolina 29935
Intrafusion Research Network - Wesley Neurology Clinic Cordova Tennessee 38018
Veracity Neuroscience LLC Memphis Tennessee 38157
Vanderbilt University Medical Center Nashville Tennessee 37232
Texas Neurology. P.A. Dallas Texas 75214
Baylor College of Medicine Houston Texas 77030
Houston Methodist Neurological Institute Houston Texas 77030
Central Texas Neurology Consultants Round Rock Texas 78681
The University of Vermont Medical Center Burlington Vermont 05401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03617367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2022 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03617367 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →